Rievent · Enduring Material
Neoadjuvant Therapy in Recurrent High-Risk Cutaneous Squamous Cell Carcinoma: Advancing Multidisciplinary Decision-Making
This mock tumor board CME/CE activity examines multidisciplinary decision-making around neoadjuvant immunotherapy and surgery in the setting of recurrent high-risk cSCC.